DEST — Destiny Pharma Share News
0.000.00%
- £3.83m
- -£2.55m
REG - Destiny Pharma PLC - Director Dealing
AnnouncementREG - Destiny Pharma PLC - Result of Annual General Meeting
AnnouncementREG - Destiny Pharma PLC - Dr Debra Barker Appointed Interim CEO
AnnouncementREG - Destiny Pharma PLC - Grant of Share Options
AnnouncementREG - AIM - AIM Notice - 03/05/2023
AnnouncementREG - Destiny Pharma PLC - Positive results from SPOR-COV® research
AnnouncementREG - Destiny Pharma PLC - Posting of Annual Report and Notice of AGM
AnnouncementREG - Destiny Pharma PLC - Exercise of Options and Total Voting Rights
AnnouncementREG - Destiny Pharma PLC - Audited results for year ended 31 December 2022
AnnouncementREG - Destiny Pharma PLC - Landmark data published on NTCD-M3
AnnouncementREG - Destiny Pharma PLC - Notice of Results and Investor Presentation
AnnouncementREG - Destiny Pharma PLC - Landmark XF-73 Phase 2 data published in journal
AnnouncementREG - Destiny Pharma PLC - Result of General Meeting and Total Voting Rights
AnnouncementREG - Destiny Pharma PLC - Result of Open Offer
AnnouncementREG - Destiny Pharma PLC - Exercise of Options and Total Voting Rights
AnnouncementREG - Destiny Pharma PLC - Holding(s) in Company
AnnouncementREG - Destiny Pharma PLC - Posting of Circular and Notice of General Meeting
AnnouncementREG - Destiny Pharma PLC - Director/PDMR Shareholding
AnnouncementREG - Destiny Pharma PLC - Agreement with Sebela Pharmaceutical for NTCD-M3
Announcement